Medicinal Cannabis Matters: Friday Roundup - 7 November 2025
Welcome to this week’s round-up in medicinal cannabis, and the first week of Medicinal Cannabis Awareness Month. As awareness continues to grow, we focus on three impactful developments: a powerful personal story of over-medication transforming into relief through cannabis, emerging clinical evidence for back-pain treatment, and new possibilities in neuropsychiatric care where medicinal cannabis is beginning to receive serious attention.
A “Zombie” on Painkillers: One Man’s Turning Point
A Scottish man described as having become a “zombie” under chronic prescription pain-killer use has spoken about how moving to medicinal cannabis restored his sense of self and functionality. His narrative emphasises an overwhelming clinical issue: when long-term opioid or heavy analgesic use leaves patients sedated, cognitively dulled or functionally impaired, the search for alternatives becomes urgent.
In his case, medicinal cannabis was introduced under supervision and he reported clearer cognition, greater alertness and better daily performance. For many patients, the change is not simply about pain-relief, but reclaiming identity.
Back Pain Breakthrough: Medicinal Cannabis Shows Real Promise
New research offers some of the strongest clinical evidence yet that medicinal cannabis-based treatments may help chronic lower-back pain. A European trial documented significant reductions in pain intensity, improved sleep and better physical function compared with placebo. Patients in the study also reported feeling more able to carry out day-to-day activities that had previously been limited by discomfort and stiffness.
Many people using medicinal cannabis for back pain describe being able to reduce their reliance on conventional painkillers, better manage flare-ups and regain a sense of control over their mobility and wellbeing. These findings reinforce what many patients have already experienced: medicinal cannabis can provide meaningful and sustained relief where other approaches have fallen short.
Medicinal Cannabis in Neuropsychiatric Care
An article in Psychology Today discusses how medicinal cannabis is beginning to find a place in complex neuropsychiatric treatment, including disorders where agitation, sleep disruption or behavioural symptoms dominate. It highlights how medicinal cannabis may interact with the endocannabinoid system, modulating mood, neuro-inflammation and neural plasticity.
This development highlights that medicinal cannabis is no longer solely about pain or symptom relief, it is starting to reshape thinking across neurology, psychiatry and combined-care pathways.
These three stories present a clear picture: for patients caught in the cycle of heavy medication, chronic pain or neuropsychiatric burden, medicinal cannabis is increasingly part of the conversation.
If you are considering whether medicinal cannabis might support your health and well-being, the first step is to check your eligibility. The process is clear and confidential, whether you’re based in England, Wales, Scotland, Northern Ireland or the Channel Islands.
Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.